This announcement is a separate document:
スズケン：スズケン・FRONTEO・塩野義製薬、3社協業により会話型認知症診断支援AIプログラムの社会実装を目指す
Suzuken: Suzuken, FRONTEO, and Shionogi Pharmaceutical aim for social implementation of an AI program to support conversational dementia diagnosis through collaboration between 3 companies
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.